The Oncolytic Virus Immunotherapy Market to look through AI-based genomics at a CAGR of 12%

Introduction:
Oncolytic virus immunotherapy is an emerging field of cancer treatment that involves using viruses to target and destroy cancer cells while leaving healthy cells intact. This type of therapy is gaining popularity in the cancer treatment space due to its potential to effectively treat a wide range of cancer types with fewer side effects than traditional chemotherapy and radiation therapy. The global oncolytic virus immunotherapy market is expected to grow significantly in the coming years.

Market Overview:

A new study by Persistence Market Research predicts that the global oncolytic virus immunotherapy market will be valued at ~ US$ 214 Mn by 2029-end, expanding at a promising CAGR of ~12% during the forecast period of 2019-2029. Over the past five years, more than 70 new cancer treatments have been launched and are utilized for treatment in over 20 different types of tumor. Moreover, new treatment options are available since the past five years, and the surge in innovation is anticipated to increase the number of candidates in clinical stage development by an outsized and varied group of biopharmaceutical companies. Further, the pipeline of cancer drugs in early clinical development has increased by more than 60% over the past decade, with almost 90% of the focus on targeted agents.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/15262

Company Profiles:

BioVex, Inc. (Amgen, Inc.)
Cold Genesys, Inc.
DNAtrix Therapeutics
Genelux Corporation
Lokon Pharma AB
Oncolytics Biotech, Inc.
ORYX GmbH & Co. KG
PsiOxus Therapeutics
SillaJen, Inc.
Sorrento Therapeutics, Inc.
Takara Bio
Targovax ASA
Transgene sa
Turnstone Biologics
VCN Biosciences
Viralytics Ltd. (Merck & Co., Inc.)
Vyriad
Shanghai Sunway Biotech

Drivers and Restraints:

One of the major drivers for the growth of the oncolytic virus immunotherapy market is the increasing prevalence of cancer worldwide. Additionally, increasing investments in research and development of oncolytic viruses and the potential for combination therapy with other immunotherapies is also driving the growth of this market.
The high cost associated with the treatment and the need for specialized infrastructure for their administration is a major restraint for the growth of the oncolytic virus immunotherapy market. Additionally, concerns about the potential for the development of resistance to oncolytic viruses may limit their long-term efficacy.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/15262

Key Segments of the Oncolytic Virus Immunotherapy Market

Indication

Melanoma
Bladder Cancer*
Prostate Cancer*
Colorectal Cancer*
Ovarian Cancer*
Lung Cancer*
Breast Cancer*
Myeloma*
Others*

End User

Hospitals
Specialty Clinics
Cancer Research Institutes

Region

North America
Europe

If You Want To Know The Business Opportunity/Market Value, Purchase The Premium Insight @ https://www.persistencemarketresearch.com/checkout/15262

Related Reports:

Immuno-Oncology Market
https://www.persistencemarketresearch.com/market-research/immunooncology-market.asp

Ophthalmic Packaging Market
https://www.persistencemarketresearch.com/market-research/ophthalmic-packaging-market.asp

Opioids Market
https://www.persistencemarketresearch.com/market-research/opioids-market.asp

DNA and RNA Sample Preparation Market
https://www.persistencemarketresearch.com/market-research/dna-rna-sample-preparation-market.asp

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.